All the cell lines tested expressed BRD2, BRD3 and BRD4 at least two times more than normal mesenchymal stem cells (MSCs), except the SK-N-MC cells, potentially because of their neuroblastoma origin (Figure 1A). The gene discussed is BRD4; the disease is neuroblastoma.